KR20060073584A
(en)
*
|
2003-07-29 |
2006-06-28 |
시그너쳐 알 앤드 디 홀딩스, 엘엘씨 |
Amino acid prodrugs
|
US8173840B2
(en)
|
2003-07-29 |
2012-05-08 |
Signature R&D Holdings, Llc |
Compounds with high therapeutic index
|
US7589233B2
(en)
|
2003-07-29 |
2009-09-15 |
Signature R&D Holdings, Llc |
L-Threonine derivatives of high therapeutic index
|
ZA200605383B
(en)
|
2003-12-29 |
2008-06-25 |
Sepracor Inc |
Pyrrole and pyrazole daao inhibitors
|
KR101142583B1
(en)
*
|
2004-01-07 |
2012-05-11 |
세이가가쿠 고교 가부시키가이샤 |
Hyaluronic acid derivative and drug containing the same
|
WO2006017351A1
(en)
|
2004-07-12 |
2006-02-16 |
Xenoport, Inc. |
Prodrugs of propofol, compositions and uses thereof
|
EP1964578A3
(en)
*
|
2005-05-05 |
2008-11-05 |
Chroma Therapeutics Limited |
Alpha aminoacid ester-drug conjugates hydrolysable by carboxylesterase
|
EP2789341A3
(en)
*
|
2005-11-11 |
2015-01-14 |
V. Ravi Chandran |
O-acetylated amino acids as anti-platelet agents and nutritional supplements
|
WO2007081542A2
(en)
|
2006-01-06 |
2007-07-19 |
Sepracor Inc. |
Tetralone-based monoamine reuptake inhibitors
|
RU2430913C2
(en)
|
2006-01-06 |
2011-10-10 |
Сепракор Инк. |
Cycloalkylamines as monoamine reuptake inhibitors
|
US7696166B2
(en)
|
2006-03-28 |
2010-04-13 |
Albany Molecular Research, Inc. |
Use of cyclosporin alkyne/alkene analogues for preventing or treating viral-induced disorders
|
US7696165B2
(en)
|
2006-03-28 |
2010-04-13 |
Albany Molecular Research, Inc. |
Use of cyclosporin alkyne analogues for preventing or treating viral-induced disorders
|
DK2013835T3
(en)
|
2006-03-31 |
2015-12-14 |
Sunovion Pharmaceuticals Inc |
Preparation of chiral amides and AMINES
|
US7884124B2
(en)
|
2006-06-30 |
2011-02-08 |
Sepracor Inc. |
Fluoro-substituted inhibitors of D-amino acid oxidase
|
CA2938241A1
(en)
|
2006-07-06 |
2008-01-10 |
Cytovia, Inc. |
Substituted 4-aryl-chromene as activator of caspases and inducer of apoptosis and as antivascular agent and the use thereof
|
CN1907954B
(en)
*
|
2006-08-16 |
2011-11-23 |
重庆医科大学医药研究所 |
Water-soluble derivative of anesthetic 2,6-diisopropyl phenol and preparation method thereof
|
CA2668070A1
(en)
|
2006-10-30 |
2008-05-08 |
Chroma Therapeutics Ltd. |
Hydroxamates as inhibitors of histone deacetylase
|
US7902252B2
(en)
|
2007-01-18 |
2011-03-08 |
Sepracor, Inc. |
Inhibitors of D-amino acid oxidase
|
BRPI0811639A2
(en)
|
2007-05-31 |
2014-09-30 |
Sepracor Inc |
FENY CYCLOAKILAMINES REPLACED AS MONOAMINE RECAPTATION INHIBITORS
|
US20090054450A1
(en)
*
|
2007-06-19 |
2009-02-26 |
Ironwood Pharmaceuticals, Inc. |
Compositions and methods of use for treating or preventing lipid related disorders
|
US8778953B2
(en)
|
2008-02-29 |
2014-07-15 |
Chroma Therapeutics Ltd. |
Inhibitors of P38 map kinase
|
TWI503101B
(en)
*
|
2008-12-15 |
2015-10-11 |
Proteus Digital Health Inc |
Body-associated receiver and method
|
AU2009327322A1
(en)
|
2008-12-19 |
2011-06-30 |
Pinnacle Pharmaceuticals, Inc. |
Phenazopyridine compounds
|
CN102596896A
(en)
*
|
2009-06-24 |
2012-07-18 |
夏尔有限责任公司 |
Mexiletine amino acid and peptide prodrugs and uses thereof
|
WO2011060049A2
(en)
|
2009-11-12 |
2011-05-19 |
The Regents Of The University Of Michigan |
Spiro-oxindole mdm2 antagonists
|
MX2012008922A
(en)
|
2010-02-01 |
2012-10-05 |
Proteus Digital Health Inc |
Data gathering system.
|
CN101906039B
(en)
*
|
2010-06-23 |
2013-05-08 |
四川大学华西医院 |
Hydroxyl acid ester compound of substituted phenol, preparation method and application in drug
|
MX2010011006A
(en)
*
|
2010-10-06 |
2012-04-18 |
Senosiain S A De C V Lab |
New salt of a pyrimidin derivative.
|
UA109464C2
(en)
|
2010-11-12 |
2015-08-25 |
Дзе Ріджентс Оф Дзе Юніверсіті Оф Мічіган |
Spiro-oxindoles as mdm2 antagonists
|
US20120196933A1
(en)
*
|
2010-12-23 |
2012-08-02 |
Richard Franklin |
Mexiletine prodrugs
|
CA2835422C
(en)
|
2011-05-11 |
2016-10-11 |
The Regents Of The University Of Michigan |
Spiro-oxindole mdm2 antagonists
|
FR2976944A1
(en)
|
2011-06-21 |
2012-12-28 |
Centre Nat Rech Scient |
PEPTIDE PRODUCTS
|
WO2015112603A1
(en)
|
2014-01-21 |
2015-07-30 |
Proteus Digital Health, Inc. |
Masticable ingestible product and communication system therefor
|
WO2014037832A2
(en)
|
2012-09-06 |
2014-03-13 |
Mahesh Kandula |
Compositions and methods for the treatment of epilepsy and neurological diseases
|
EP2773378B1
(en)
|
2011-10-31 |
2016-08-10 |
Larsen, Claus Selch |
Prodrugs of non-steroid anti-inflammatory agents (nsaids)
|
ES2802251T3
(en)
|
2012-01-06 |
2021-01-18 |
Novartis Ag |
Heterocyclic compounds and methods for their use
|
WO2013167985A1
(en)
|
2012-05-07 |
2013-11-14 |
Mahesh Kandula |
Compositions and methods for the treatment of neurological disorders
|
CN104379589A
(en)
*
|
2012-05-07 |
2015-02-25 |
塞利克斯比奥私人有限公司 |
Prodrugs of anti-platelet agents
|
US9399634B2
(en)
|
2012-05-07 |
2016-07-26 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of depression
|
EP2847158A4
(en)
|
2012-05-07 |
2015-12-30 |
Cellix Bio Private Ltd |
Compositions and methods for treatment of neuromuscular disorders and neurodegenerative disorders
|
US9309233B2
(en)
|
2012-05-08 |
2016-04-12 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of blood clotting disorders
|
US9403826B2
(en)
|
2012-05-08 |
2016-08-02 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of inflammatory disorders
|
US9266823B2
(en)
|
2012-05-08 |
2016-02-23 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of parkinson's disease
|
US9434704B2
(en)
|
2012-05-08 |
2016-09-06 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of neurological degenerative disorders
|
WO2013167991A1
(en)
|
2012-05-08 |
2013-11-14 |
Mahesh Kandula |
Compositions and methods for the treatment of metabolic disorders
|
WO2013168000A1
(en)
|
2012-05-10 |
2013-11-14 |
Mahesh Kandula |
Compositions and methods for the treatment of severe pain
|
US9315478B2
(en)
|
2012-05-10 |
2016-04-19 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of metabolic syndrome
|
WO2013168012A1
(en)
|
2012-05-10 |
2013-11-14 |
Mahesh Kandula |
Compositions and methods for the treatment of respiratory disorders
|
WO2013168015A1
(en)
|
2012-05-10 |
2013-11-14 |
Mahesh Kandula |
Compositions and methods for the treatment of asthma and allergy
|
WO2013168004A2
(en)
|
2012-05-10 |
2013-11-14 |
Mahesh Kandula |
Compositions and methods for the treatment of fibromyalgia pain
|
WO2013168001A1
(en)
|
2012-05-10 |
2013-11-14 |
Mahesh Kandula |
Compositions and methods for the treatment of moderate to severe pain
|
US9499527B2
(en)
|
2012-05-10 |
2016-11-22 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of familial amyloid polyneuropathy
|
US9403857B2
(en)
|
2012-05-10 |
2016-08-02 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of metabolic syndrome
|
WO2013167999A2
(en)
|
2012-05-10 |
2013-11-14 |
Mahesh Kandula |
Compositions and methods for the treatment of neurologic diseases
|
US9273061B2
(en)
|
2012-05-10 |
2016-03-01 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of chronic pain
|
WO2013168005A2
(en)
|
2012-05-10 |
2013-11-14 |
Mahesh Kandula |
Compositions and methods for the treatment of restless leg syndrome and fibromyalgia
|
US9233161B2
(en)
|
2012-05-10 |
2016-01-12 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of neurological conditions
|
US9499526B2
(en)
|
2012-05-10 |
2016-11-22 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of neurologic diseases
|
CA3189252A1
(en)
|
2012-05-16 |
2013-11-21 |
Techfields Pharma Co., Ltd. |
High penetration prodrug compositions and pharmaceutical composition thereof for treatment of pulmonary conditions
|
CA2873104A1
(en)
|
2012-05-23 |
2013-11-28 |
Cellixbio Private Limited |
Compositions and methods for the treatment of mucositis
|
WO2013175347A2
(en)
|
2012-05-23 |
2013-11-28 |
Mahesh Kandula |
Compositions and methods for the treatment of respiratory disorders
|
CN104603097A
(en)
|
2012-05-23 |
2015-05-06 |
塞利克斯比奥私人有限公司 |
Compositions and methods for the treatment of multiple sclerosis
|
US9434729B2
(en)
|
2012-05-23 |
2016-09-06 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of periodontitis and rheumatoid arthritis
|
JP6202287B2
(en)
|
2012-05-23 |
2017-09-27 |
セリックスビオ プライヴェート リミテッド |
Compositions and methods for the treatment of inflammatory bowel disease
|
US9492409B2
(en)
|
2012-05-23 |
2016-11-15 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of local pain
|
US9108942B1
(en)
|
2014-11-05 |
2015-08-18 |
Mahesh Kandula |
Compositions and methods for the treatment of moderate to severe pain
|
US9187427B2
(en)
|
2012-08-03 |
2015-11-17 |
Cellix Bio Private Limited |
N-substituted nicotinamide compounds and compositions for the treatment migraine and neurologic diseases
|
TWI601725B
(en)
*
|
2012-08-27 |
2017-10-11 |
加拓科學公司 |
Substituted azaindole compounds, salts, pharmaceutical compositions thereof and methods of use
|
US9624168B2
(en)
|
2012-09-06 |
2017-04-18 |
Cellix Bio Private Limited |
Compositions and methods for the treatment inflammation and lipid disorders
|
WO2014037834A2
(en)
|
2012-09-08 |
2014-03-13 |
Mahesh Kandula |
Compositions and methods for the treatment of inflammation and lipid disorders
|
CN102924398B
(en)
*
|
2012-11-22 |
2015-11-18 |
安徽贝克生物制药有限公司 |
For removing the method for the corresponding isomer of efavirenz
|
CN103880754A
(en)
*
|
2012-12-21 |
2014-06-25 |
西藏海思科药业集团股份有限公司 |
Alkaline amino acid ester salt of propofol
|
WO2014151929A1
(en)
|
2013-03-15 |
2014-09-25 |
Proteus Digital Health, Inc. |
Personal authentication apparatus system and method
|
CN103263405B
(en)
*
|
2013-05-08 |
2015-04-22 |
南京医科大学 |
Medicinal composition for treating diabetes, and its application
|
US9333187B1
(en)
|
2013-05-15 |
2016-05-10 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of inflammatory bowel disease
|
WO2014195961A1
(en)
|
2013-06-04 |
2014-12-11 |
Mahesh Kandula |
Compositions and methods for the treatment of diabetes and pre-diabetes
|
CN103360240B
(en)
*
|
2013-07-23 |
2015-03-11 |
西安新通药物研究有限公司 |
Preparation method of high purity fenofibric acid
|
MX356850B
(en)
|
2013-09-20 |
2018-06-15 |
Proteus Digital Health Inc |
Methods, devices and systems for receiving and decoding a signal in the presence of noise using slices and warping.
|
US10084880B2
(en)
|
2013-11-04 |
2018-09-25 |
Proteus Digital Health, Inc. |
Social media networking based on physiologic information
|
WO2016110865A1
(en)
|
2015-01-06 |
2016-07-14 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of inflammation and pain
|
US9096537B1
(en)
|
2014-12-31 |
2015-08-04 |
Mahesh Kandula |
Compositions and methods for the treatment of mucositis
|
SI3701971T1
(en)
|
2014-03-14 |
2023-01-31 |
Biomolecular Holdings LLC, |
Compounds useful in preparing hybrid immunoglobulin containing non-peptidyl linkage
|
CN103951557B
(en)
*
|
2014-04-22 |
2016-06-08 |
徐州工业职业技术学院 |
A kind of method with inorganic base for catalyst preparing fenofibrate
|
US10471118B2
(en)
|
2014-05-30 |
2019-11-12 |
Case Western Reserve University |
Retinylamine derivitives for treatment of ocular disorders
|
SG11201706952VA
(en)
|
2014-09-26 |
2017-10-30 |
Cellix Bio Private Ltd |
Compositions and methods for the treatment of epilepsy and neurological disorders
|
CN107207403A
(en)
|
2014-09-29 |
2017-09-26 |
塞尔利克斯生物私人有限公司 |
Composition and method for treating multiple sclerosis
|
CN107108535B
(en)
|
2014-10-27 |
2020-04-28 |
塞尔利克斯生物私人有限公司 |
Three-component salts of monomethyl fumarate with piperazine or ethylenediamine for the treatment of multiple sclerosis
|
US9284287B1
(en)
|
2014-11-05 |
2016-03-15 |
Cellix Bio Private Limited |
Compositions and methods for the suppression of carbonic anhydrase activity
|
US9175008B1
(en)
|
2014-11-05 |
2015-11-03 |
Cellix Bio Private Limited |
Prodrugs of anti-platelet agents
|
US9290486B1
(en)
|
2014-11-05 |
2016-03-22 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of epilepsy
|
US10208014B2
(en)
|
2014-11-05 |
2019-02-19 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of neurological disorders
|
US9321716B1
(en)
|
2014-11-05 |
2016-04-26 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of metabolic syndrome
|
US9173877B1
(en)
|
2014-11-05 |
2015-11-03 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of local pain
|
US9150557B1
(en)
|
2014-11-05 |
2015-10-06 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of hyperglycemia
|
US9932294B2
(en)
|
2014-12-01 |
2018-04-03 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of multiple sclerosis
|
US9206111B1
(en)
|
2014-12-17 |
2015-12-08 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of neurological diseases
|
CN104628554A
(en)
*
|
2015-02-09 |
2015-05-20 |
徐州工程学院 |
Fenofibric acid crystal form and preparation method thereof
|
CN106146444A
(en)
*
|
2015-04-03 |
2016-11-23 |
米文君 |
A kind of new compound and application thereof
|
CN105037180B
(en)
*
|
2015-04-19 |
2017-10-10 |
安徽省逸欣铭医药科技有限公司 |
Central analgesia noval chemical compound, the Preparation method and use of a kind of double action
|
BR112018068886A2
(en)
*
|
2016-03-18 |
2019-01-22 |
Caregen Co Ltd |
finasteride conjugate with peptide
|
WO2017193562A1
(en)
*
|
2016-05-10 |
2017-11-16 |
浙江海正药业股份有限公司 |
Water soluble rapamycin derivative
|
CN106316921B
(en)
*
|
2016-08-19 |
2019-03-29 |
河南东泰制药有限公司 |
A kind of preparation method of acemetacin
|
CN108948140B
(en)
*
|
2017-05-18 |
2021-10-26 |
首都医科大学 |
warfarin-4-O-acetyl-Arg-AA eleven compounds, and synthesis, activity and application thereof
|
CN108948139B
(en)
*
|
2017-05-18 |
2021-10-26 |
首都医科大学 |
warfarin-4-O-acetyl-Arg-AA compounds, their synthesis, activity and use
|
UY38072A
(en)
|
2018-02-07 |
2019-10-01 |
Novartis Ag |
COMPOSITIONS DERIVED FROM BUTANOIC ESTER SUBSTITUTED WITH BISPHENYL AS INHIBITORS OF NEP, COMPOSITIONS AND COMBINATIONS OF THE SAME
|
CN108299219A
(en)
*
|
2018-02-11 |
2018-07-20 |
中国农业大学 |
O- is acylated serine derivative and the preparation method and application thereof
|
DK3678705T3
(en)
|
2018-09-14 |
2023-06-26 |
Enlitisa Shanghai Pharmaceutical Co Ltd |
Conjugates of montelukast and peptides
|